Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value: $435M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MEDIVATION INC | 600,000 | $38.62M | 8.9% | $63.87 | — | COM | 58501N101 |
| — | CUBIST PHARMACEUTICALS INC | 300,000 | $21.95M | 5.0% | $68.87 | — | COM | 229678107 |
| PBYI | PUMA BIOTECHNOLOGY INC | 207,500 | $21.61M | 5.0% | $60.82 | +93.3% | COM | 74587V107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 300,000 | $20.46M | 4.7% | $71.76 | +2.7% | COM | 09061G101 |
| — | RECEPTOS INC | 450,000 | $18.87M | 4.3% | $31.87 | — | COM | 756207106 |
| — | DYAX CORP | 2,000,000 | $17.96M | 4.1% | $7.54 | — | COM | 26746E103 |
| — | INTERCEPT PHARMACEUTICALS IN | 50,000 | $16.49M | 3.8% | $329.80 | — | COM | 45845P108 |
| — | ARROWHEAD RESEARCH CORP | 1,000,000 | $16.42M | 3.8% | $10.85 | — | COM NEW | 042797209 |
| — | IDENIX PHARMACEUTICALS INC | 2,500,000 | $15.07M | 3.5% | $5.98 | — | COM | 45166R204 |
| PTCT | PTC THERAPEUTICS INC | 550,000 | $14.38M | 3.3% | $26.39 | +1.8% | COM | 69366J200 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 100,000 | $13.87M | 3.2% | $150.52 | 0.0% | SHS USD | G50871105 |
| PRTA | PROTHENA CORP PLC | 350,000 | $13.41M | 3.1% | $32.24 | 0.0% | SHS | G72800108 |
| DXCM | DEXCOM INC | 300,000 | $12.41M | 2.9% | $7.91 | +30.6% | COM | 252131107 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,168,000 | $12.36M | 2.8% | $9.67 | +10.3% | COM | 09058V103 |
| MRK | MERCK & CO. INC NEW | 200,000 | $11.35M | 2.6% | $35.76 | 0.0% | COM | 58933Y105 |
| SGMO | SANGAMO BIOSCIENCES INC | 600,000 | $10.85M | 2.5% | $17.13 | +12.6% | COM | 800677106 |
| — | ACELRX PHARMACEUTICALS INC | 750,000 | $9.008M | 2.1% | $11.31 | — | COM | 00444T100 |
| SRNE | SORRENTO THERAPEUTICS INC | 700,000 | $8.974M | 2.1% | $11.07 | 0.0% | COM NEW | 83587F202 |
| — | TESARO INC | 300,000 | $8.844M | 2.0% | $28.24 | — | COM | 881569107 |
| ALKS | ALKERMES PLC | 200,000 | $8.818M | 2.0% | $47.58 | 0.0% | SHS | G01767105 |
| — | KARYOPHARM THERAPEUTICS INC | 280,000 | $8.649M | 2.0% | $28.04 | — | COM | 48576U106 |
| — | CLOVIS ONCOLOGY INC | 120,000 | $8.312M | 1.9% | $60.27 | — | COM | 189464100 |
| — | NANOSTRING TECHNOLOGIES INC | 400,000 | $8.26M | 1.9% | $20.65 | — | COM | 63009R109 |
| — | ARRAY BIOPHARMA INC | 1,750,000 | $8.225M | 1.9% | $5.01 | — | COM | 04269X105 |
| — | GLYCOMIMETICS INC | 469,400 | $7.665M | 1.8% | $16.33 | — | COM | 38000Q102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 300,000 | $7.299M | 1.7% | $23.59 | +7.2% | COM | 004225108 |
| — | CHIMERIX INC | 300,000 | $6.852M | 1.6% | $19.16 | — | COM | 16934W106 |
| OMER | OMEROS CORP | 500,000 | $6.035M | 1.4% | $12.28 | 0.0% | COM | 682143102 |
| GALT | GALECTIN THERAPEUTICS INC | 348,000 | $5.328M | 1.2% | $14.24 | 0.0% | COM NEW | 363225202 |
| — | PORTOLA PHARMACEUTICALS INC | 200,000 | $5.18M | 1.2% | $25.84 | — | COM | 737010108 |
| EGRX | EAGLE PHARMACEUTICALS INC | 400,000 | $5.1M | 1.2% | $13.58 | 0.0% | COM | 269796108 |
| — | ROCKWELL MED INC | 400,000 | $5.064M | 1.2% | $12.66 | — | COM | 774374102 |
| — | NOVAVAX INC | 1,000,000 | $4.53M | 1.0% | $5.12 | — | COM | 670002104 |
| — | RECRO PHARMA INC | 500,000 | $3.66M | 0.8% | $7.32 | — | COM | 75629F109 |
| — | GENVEC INC | 1,329,300 | $3.523M | 0.8% | $2.65 | — | COM NEW | 37246C307 |
| PCRX | PACIRA PHARMACEUTICALS INC | 50,000 | $3.5M | 0.8% | $52.58 | +29.4% | COM | 695127100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 50,000 | $3.357M | 0.8% | $59.65 | +29.8% | COM | 02043Q107 |
| — | AGENUS INC | 1,000,000 | $3.17M | 0.7% | $3.17 | — | COM NEW | 00847G705 |
| — | AQUINOX PHARMACEUTICALS INC | 246,877 | $3.143M | 0.7% | $12.73 | — | COM | 03842B101 |
| GERN | GERON CORP | 1,500,000 | $3.135M | 0.7% | $4.29 | -7.1% | COM | 374163103 |
| — | AUSPEX PHARMACEUTICALS INC | 100,000 | $3.076M | 0.7% | $30.76 | — | COM | 05211J102 |
| BIIB | BIOGEN IDEC INC | 10,000 | $3.059M | 0.7% | $317.43 | 0.0% | COM | 09062X103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 60,000 | $2.933M | 0.7% | $51.48 | 0.0% | COM | 90400D108 |
| — | REGULUS THERAPEUTICS INC | 200,000 | $1.804M | 0.4% | $8.21 | — | COM | 75915K101 |
| — | IDERA PHARMACEUTICALS INC | 400,000 | $1.632M | 0.4% | $4.08 | — | COM NEW | 45168K306 |
| — | CELSUS THERAPEUTICS PLC | 103,000 | $668K | 0.2% | $6.49 | — | SPONSORED ADR NE | 15119A202 |